LEMAITRE VASCULAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
LEMAITRE VASCULAR, INC. (LMAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 179.09K shares, a 42.32% increase year-over-year.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 179.83K shares, a 42.91% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 125.83K shares, a 15.04% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 148.12K shares, a 7.01% decline from fiscal 2022.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 159.28K shares, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 0.00 shares 10-Q · filed 2026-08-05 | 179.09K shares derived: sum of 3 quarters · filed 2026-08-05 | 179.09K shares derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-06 | 179.09K shares derived: sum of 2 quarters · filed 2026-05-06 | 179.09K shares derived: sum of 3 quarters · filed 2026-05-06 | 179.09K shares derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | 179.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 179.09K shares derived: sum of 2 quarters · filed 2026-02-26 | 179.09K shares derived: sum of 3 quarters · filed 2026-08-05 | 179.83K shares 10-K · filed 2026-02-26 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-05 | 741.00 shares 10-Q · filed 2025-11-07 | 126.58K shares derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 741.00 shares 10-Q · filed 2026-08-05 | 126.58K shares derived: sum of 3 quarters · filed 2026-08-05 | 126.58K shares derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | 741.00 shares 10-Q · filed 2026-05-06 | 126.58K shares derived: sum of 2 quarters · filed 2026-05-06 | 126.58K shares derived: sum of 3 quarters · filed 2026-05-06 | 126.58K shares derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | 125.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 125.83K shares derived: sum of 2 quarters · filed 2026-02-26 | 125.83K shares derived: sum of 3 quarters · filed 2026-02-26 | 125.83K shares 10-K · filed 2026-02-26 | ||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-07 | 0.00 shares 10-Q · filed 2025-11-07 | 146.46K shares derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 0.00 shares 10-Q · filed 2025-08-06 | 146.46K shares derived: sum of 3 quarters · filed 2026-02-26 | 146.46K shares derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 222.00 shares 10-Q · filed 2024-05-10 | 146.46K shares derived: sum of 2 quarters · filed 2026-02-26 | 146.46K shares derived: sum of 3 quarters · filed 2026-02-26 | 147.91K shares derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | 146.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 146.46K shares derived: sum of 2 quarters · filed 2026-02-26 | 147.91K shares derived: sum of 3 quarters · filed 2026-02-26 | 148.12K shares 10-K · filed 2026-02-26 | ||
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 1.46K shares derived: sum of 2 quarters · filed 2024-11-08 | 1.66K shares 10-Q · filed 2024-11-08 | 158.88K shares derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | 1.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.66K shares 10-Q · filed 2024-08-08 | 158.88K shares derived: sum of 3 quarters · filed 2025-02-28 | 159.95K shares derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | 200.00 shares 10-Q · filed 2024-05-10 | 0.00 shares 10-Q · filed 2023-05-09 | 157.42K shares derived: sum of 2 quarters · filed 2025-02-28 | 158.49K shares derived: sum of 3 quarters · filed 2025-02-28 | 159.47K shares derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | 157.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 158.29K shares derived: sum of 2 quarters · filed 2025-02-28 | 159.28K shares derived: sum of 3 quarters · filed 2025-02-28 | 159.28K shares 10-K · filed 2025-02-28 | ||
| 2022-09-30 | 1.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 2.05K shares derived: sum of 2 quarters · filed 2023-11-07 | 2.05K shares 10-Q · filed 2023-11-07 | 161.33K shares derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | 984.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 984.00 shares 10-Q · filed 2023-08-08 | 160.26K shares derived: sum of 3 quarters · filed 2024-02-29 | 160.26K shares derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-09 | 159.28K shares derived: sum of 2 quarters · filed 2024-02-29 | 159.28K shares derived: sum of 3 quarters · filed 2024-02-29 | 159.28K shares derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | 159.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 159.28K shares derived: sum of 2 quarters · filed 2024-02-29 | 159.28K shares derived: sum of 3 quarters · filed 2024-02-29 | 159.28K shares 10-K · filed 2024-02-29 | 151.16K shares 10-K · filed 2022-02-28 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-08 | 0.00 shares 10-Q · filed 2022-11-08 | 131.16K shares derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | 0.00 shares 10-Q · filed 2022-08-05 | 131.16K shares derived: sum of 3 quarters · filed 2024-02-29 | 131.16K shares derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-10 | 131.16K shares derived: sum of 2 quarters · filed 2024-02-29 | 131.16K shares derived: sum of 3 quarters · filed 2024-02-29 | 151.16K shares derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2020-12-31 | 131.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 131.16K shares derived: sum of 2 quarters · filed 2024-02-29 | 151.16K shares derived: sum of 3 quarters · filed 2024-02-29 | 151.16K shares 10-K · filed 2024-02-29 | 222.11K shares 10-K · filed 2021-03-12 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 20.00K shares derived: sum of 2 quarters · filed 2021-11-04 | 20.00K shares 10-Q · filed 2021-11-04 | 215.38K shares derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | 20.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 20.00K shares 10-Q · filed 2021-08-05 | 215.38K shares derived: sum of 3 quarters · filed 2022-02-28 | 215.38K shares derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-10 | 195.38K shares derived: sum of 2 quarters · filed 2022-02-28 | 195.38K shares derived: sum of 3 quarters · filed 2022-02-28 | 195.38K shares derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | 195.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 195.38K shares derived: sum of 2 quarters · filed 2022-02-28 | 195.38K shares derived: sum of 3 quarters · filed 2022-02-28 | 195.38K shares 10-K · filed 2022-02-28 | ||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-08 | 0.00 shares 10-Q · filed 2019-11-08 | 280.42K shares derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 0.00 shares 10-Q · filed 2019-08-06 | 280.42K shares derived: sum of 3 quarters · filed 2020-05-08 | 280.42K shares derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-05-08 | 280.42K shares derived: sum of 2 quarters · filed 2020-05-08 | 280.42K shares derived: sum of 3 quarters · filed 2020-05-08 | 280.42K shares derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | 280.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | 280.42K shares derived: sum of 2 quarters · filed 2019-11-08 | 280.42K shares derived: sum of 3 quarters · filed 2019-11-08 | 280.42K shares 10-K · filed 2019-03-11 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-08 | 0.00 shares 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 0.00 shares 10-Q · filed 2019-08-06 | ||||
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-06 | |||||
| 2017-12-31 | 219.41K shares 10-K · filed 2018-03-09 | |||||
| 2016-12-31 | 510.75K shares 10-K · filed 2017-03-09 | |||||
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 0.00 shares 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | 0.00 shares 10-Q · filed 2017-05-04 | |||||
| 2015-12-31 | 511.23K shares 10-K · filed 2016-03-10 | |||||
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | 0.00 shares 10-Q · filed 2016-08-05 | ||||
| 2015-03-31 | 0.00 shares 10-Q · filed 2016-05-06 | |||||
| 2014-12-31 | 508.54K shares 10-K · filed 2015-03-18 | |||||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-07 | |||||
| 2013-12-31 | 367.28K shares 10-K · filed 2014-03-21 | |||||
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 0.00 shares 10-Q · filed 2014-08-07 | ||||
| 2013-03-31 | 0.00 shares 10-Q · filed 2014-05-08 | |||||
| 2012-12-31 | 304.17K shares 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |